No Data
Earnings Preview: HIMS to Report Financial Results Post-market on November 04
Truist Financial Maintains Hims & Hers Health(HIMS.US) With Hold Rating
BofA Securities Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Maintains Target Price $25
Hims & Hers Health Options Spot-On: On October 30th, 101.6K Contracts Were Traded, With 290.06K Open Interest
Hims & Hers Health Stock Is Trading Lower Wednesday: Here's Why
Reported Earlier, 'Novo Nordisk's Ozempic and Wegovy, Long in Shortage, Are Now Listed as Available by FDA; It Remains Unclear How the Update Could Affect Patients as Well as Compounders' - STAT News
2010 citscwb : Are you falling this much?
Djakin470 : 13% down. Is there more downside. I am looking for a nice entry spot before earnings next week.
Zestful : Me too
104238715 : they going to demolish this to 17.40 today and after earnings, sink it further to 15+. I will be buying at that level
Kimpten OP Djakin470 : potentially but short term fluctuations doesn't impact its long term thesis